About 214,000 results
Open links in new tab
  1. Teva Pharmaceutical Industries Ltd. - Teva’s New Real-World …

    Apr 16, 2024 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis …

  2. Clinical Study Results for AUSTEDO XR® HD Chorea Treatment

    Clinical study details for AUSTEDO® (deutetrabenazine) tablets and treatment of Huntington's Disease chorea. See safety info and boxed warning.

  3. Phase 4 Data Support Effectiveness of Deutetrabenazine in …

    1 day ago · Teva Pharmaceuticals announced data from the ongoing real-world phase 4 study, coined IMPACT-TD Registry, evaluating the efficacy of deutetrabenazine (Austedo) tablets …

  4. Teva Real-World Study Finds AUSTEDO and AUSTEDO XR

    Nov 10, 2025 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis …

  5. Teva Pharmaceuticals Reports Positive Real-World Data on AUSTEDO

    Nov 7, 2025 · The data presented at a significant neuroscience congress demonstrate the effectiveness of AUSTEDO and AUSTEDO XR in reducing the severity of involuntary …

  6. Teva’s New Real-World Evidence Presented at the 2024 AAN …

    Apr 16, 2024 · The most common adverse reactions for AUSTEDO (4% and greater than placebo) in controlled clinical studies in patients with tardive dyskinesia were nasopharyngitis …

  7. Study Explores Tardive Dyskinesia Outcomes With …

    Nov 12, 2024 · The survey examined patient-reported ease of use, effectiveness, and satisfaction. In this interim analysis of data from 131 respondents, results revealed that 87% reported …

  8. Teva to Present New Data Supporting Safety, Efficacy and Real …

    AUSTEDO ® XR (deutetrabenazine) extended-release tablets and AUSTEDO ® (deutetrabenazine) tablets are indicated in adults for the treatment of chorea associated with …

  9. Aug 1, 2025 · References Austedo/Austedo XR (deutetrabenazine) [prescribing information]. Parsippany, NJ: Teva Neuroscience, Inc; February 2025. Indirect tolerability compar al. Long …

  10. Clinical Studies Results | AUSTEDO (deutetrabenazine)

    See Important Safety Information, including Boxed Warning. Learn about the results of the clinical studies done for AUSTEDO XR® (deutetrabenazine) tablets.